Insplorion has announced that the ATEX certification process will be delayed by another estimated th...
Redeye comments on Faron’s decision to trigger the second €10m tranche of the Heights Capital Manage...
Nokian Panimo cut its 2025 EBITDA margin guidance due to weaker-than-expected profitability after th...
Redeye comments on CMS’s finalised reimbursement rates, effective from January 2026.
Today, I-Tech announced a strategic partnership (MoU) together with Chinese Havey, to develop and co...
Redeye provides a short comment on Catella's divestment of Valuation France to Newmark Group, announ...
Redeye endorses today’s news that Sprint Bioscience has sold its TREX1 program to Gilead Sciences, i...
Systemair stod inför fortsatt valutamotvind under hösten, vilket neutraliserade tillväxten och höll ...
Prospekterings- och gruvutvecklingsbolaget Bluelake Mineral har påbörjat arbetet med en PFS (Pre-Fea...
Solwers' Q3 sales were in line with our expectation, while EBITA was 8% ahead of our estimate, a cl...
Flexion’s latest quarterly update marks a period of transition, with financial performance slightly ...
Redeye comments on Heliospectra’s rights issue outcome and has adjusted its fair value range to refl...
* Waiting for sales of Dållebo, Boarp and Fågelås wind projects * ~470 MW under construction * Tradi...
Solwers reported its results for Q3 with sales of EUR 17.
* Room for M&A to drive earnings growth * Funding costs are coming down significantly * 2026e P/CEPS...
HomeMaid redovisade ökad nettoomsättning och EBITA i det tredje kvartalet.
Studentbostäder i Norden hyresintäkter steg med 6% till 112,8 mkr och driftnettot ökade med 9% till ...
Redeye comments on the cost savings in IM. The initiative is reasonable and was expected following m...
Redeye takes a positive stance towards Vertiseit’s acquisition of Muse, expanding the offering into ...
Redeye comments on Cantargia's third quarter report 2025.
